Comment from Plotts Dawn
AnonymousSupportIndividual
Summary: An individual patient who uses peptide therapy for a chronic autoimmune condition argues against restricting access to compounded peptides. They contend that medical decisions should be personalized and that limiting access will only drive patients toward less safe alternatives.
I have lived with a chronic autoimmune condition for years. While conventional medicine helped manage my condition, it never addressed the underlying issues or restored my quality of life.
Working with a qualified healthcare provider, peptide therapy has become an important part of my personalized treatment plan. It has helped me regain my health, improve my daily functioning, and return to living a full and active life.
Please do not take away access to compounded peptides for patients who have few other options. Medical decisions should be made by patients and their healthcare providers based on individual needs, not a one size fits all approach. Restricting access will not eliminate the need. It will only push people toward less safe alternatives.
Please preserve access to compounded peptides for the patients who depend on them.